Dark Forest Capital Management LP Abb Vie Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $233,482 - $290,553	1,762 New	1,762 $237,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $8,670 - $11,022	-63 Reduced 98.44%	1 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $8,446 - $10,480	64 New	64 $10,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $133,857 - $169,368	-1,246 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $386,444 - $438,672	-3,632 Reduced 74.46%	1,246 $134,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $513,214 - $571,750	4,878 New	4,878 $549,000

3,785

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.